All In MedTech

FDA Clearance Tracker · P140017-S006

MELODY TRANSCATHETER PULMONARY VALVE , ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 22, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 22, 2017

Approved

Time to decision

180 days

Received Nov 23, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P140017-S006
Device name
MELODY TRANSCATHETER PULMONARY VALVE , ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
Applicant location
Mounds View, MN
Received
Nov 23, 2016
Decided
May 22, 2017
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140017

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for updates to the Melody Transcatheter Pulmonary Valve System Instructions for Use to reflect the final results of the Long-Term Follow-up Post-Approval Study.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.